A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients

被引:20
|
作者
Roe, Kevin
机构
[1] San Jose, CA
关键词
brain infections; latent infections; protozoa; protozoan infections; SARS-CoV-2; mortality; INHIBITION; INFECTION;
D O I
10.1002/jnr.24917
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Unusual mortality rate differences and symptoms have been experienced by COVID-19 patients, and the postinfection symptoms called Long COVID-19 have also been widely experienced. A substantial percentage of COVID-19-infected individuals in specific health categories have been virtually asymptomatic, several other individuals in the same health categories have exhibited several unusual symptoms, and yet other individuals in the same health categories have fatal outcomes. It is now hypothesized that these differences in mortality rates and symptoms could be caused by a SARS-CoV-2 virus infection acting together with one or more latent pathogen infections in certain patients, through mutually beneficial induced immune cell dysfunctions, including T-cell exhaustion. A latent pathogen infection likely to be involved is the protozoan parasite Toxoplasma gondii, which infects approximately one third of the global human population. Furthermore, certain infections and cancers that cause T-cell exhaustion can also explain the more severe outcomes of other COVID-19 patients having several disease and cancer comorbidities.
引用
收藏
页码:2367 / 2376
页数:10
相关论文
共 50 条
  • [21] Undervaccination and severe COVID-19 outcomes
    Morris, James
    LANCET, 2025, 405 (10474): : 301 - 302
  • [22] Undervaccination and severe COVID-19 outcomes
    Joffe, Ari
    LANCET, 2025, 405 (10475): : 301 - 301
  • [23] OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
    Ho, Timothy D.
    Nandakumar, Shonit
    Zhong, Lily
    To, Magnus
    Heineke, Hyunju
    Ayutyanont, Napatkamon
    Kubomoto, Scott
    Sangodkar, Sandeep
    Biswas, Mimi S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2077 - 2077
  • [24] Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
    Garcia-Saleem, Tiffany J.
    Stonesifer, Connor J.
    Geskin, Larisa J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB203 - AB203
  • [25] COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis
    Baker, Mairead
    Pakhchanian, Haig
    Raiker, Rahul
    Deng, Min
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB153 - AB153
  • [26] T cell responses in patients with COVID-19
    Zeyu Chen
    E. John Wherry
    Nature Reviews Immunology, 2020, 20 : 529 - 536
  • [27] T cell response in patients with COVID-19
    Liu, Lian
    Xu, Ling
    Lin, Chen
    BLOOD SCIENCE, 2020, 2 (03): : 76 - 78
  • [28] T cell responses in patients with COVID-19
    Chen, Zeyu
    John Wherry, E.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (09) : 529 - 536
  • [29] The Role of the Endothelium in Severe COVID-19
    Soares Brandao, Simone Cristina
    Albuquerque Madruga Godoi, Emmanuelle Tenorio
    Xavier Ramos, Julia de Oliveira
    Magalhaes Pessoa de Melo, Leila Maria
    Dompieri, Luca Terracini
    Brindeiro Filho, Djair Falcao
    Cavalcanti Sarinho, Emanuel Savio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (06) : 1184 - 1189
  • [30] Characterization of T lymphocytes in severe COVID-19 patients
    Fenoglio, Daniela
    Dentone, Chiara
    Parodi, Alessia
    Di Biagio, Antonio
    Bozzano, Federica
    Vena, Antonio
    Fabbi, Marina
    Ferrera, Francesca
    Altosole, Tiziana
    Bruzzone, Bianca
    Giacomini, Mauro
    Pelosi, Paolo
    De Maria, Andrea
    Bassetti, Matteo
    De Palma, Raffaele
    Filaci, Gilberto
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5608 - 5613